ARCHIVES

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

This article is from The Cancer Letter archive.

Vol. 18 No. 40 | October 16, 1992

Download PDF Visit The Full Archive

Related Articles

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed

April 6, 1984

NIH, Myriad Talked About CRADA, Didn’t Agree, Varmus Writes

November 4, 1994

Genentech’s Ferrara Selected for GM Award.

June 23, 2006

NCI, Advisers Lean To Smaller Increases For R01a, Philosophy Of Spreading Money Among More Grants

January 15, 1982

Bills Introduced To Raise Cigarette Excise Tax By Bradley, Andrews

March 12, 1993